This activity includes patient counseling videos.
Program Description
Hereditary angioedema (HAE) is a serious, potentially fatal disease of intermittent and recurring swelling that typically occurs in an individual’s limbs and face, as well as the gastrointestinal tract and airways. The current recommended treatment for HAE includes a combination of on-demand and short- and/or long-term prophylactic treatment to reduce the number of life-threatening attacks; however, use of prophylaxis depends on the frequency and severity of attacks, potential adverse effects of different medications, the cost of treatment, and the route and schedule of administration. As accessible members of the health care community, pharmacists play a vital role in not only the identification of HAE, but referrals for treatment and monitoring medications for efficacy and adverse effects. Through this activity, pharmacists will become equipped to help patients overcome treatment barriers and improve patient outcomes through education regarding new and emerging therapies for HAE.
Target audience: Specialty pharmacists
Type of activity: Application
Release date: September 1, 2023
Expiration date: September 1, 2024
Time to complete activity: 1.0 hour
Learner level: Foundational
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Discover the burden and quality of life implications of hereditary angioedema (HAE)
- Explore the importance of early diagnosis and prompt intervention, including prophylaxis and on-demand acute medications
- Examine the safety and efficacy of current and emerging therapies for HAE
- Identify the role of pharmacists in improving outcomes for patients with HAE through collaboration with the multidisciplinary team and patient education
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
